Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kelsey E. Hart
Institution:
Proteus Digital Health
Observed institution:
Proteus Digital Health
ORCID:
0009-0003-2287-6783
Observed ORCID:
0009-0003-2287-6783
OpenAlex ID:
A5141236821
Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors
2026
·
Douglas V. Faget
, Rachel E. Brewer
, et al.
·
Clinical Cancer Research
·
2
Data from Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors
2026
·
Douglas V. Faget
, Rachel E. Brewer
, et al.
Supplemental Figures 1-11 from Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors
2026
·
Douglas V. Faget
, Rachel E. Brewer
, et al.
Supplemental Table 3 from Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors
2026
·
Douglas V. Faget
, Rachel E. Brewer
, et al.
Supplemental Methods 1 from Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors
2026
·
Douglas V. Faget
, Rachel E. Brewer
, et al.
Supplemental Table 2 from Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors
2026
·
Douglas V. Faget
, Rachel E. Brewer
, et al.
Supplemental Table 1 from Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors
2026
·
Douglas V. Faget
, Rachel E. Brewer
, et al.
Supplemental Table 4 from Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors
2026
·
Douglas V. Faget
, Rachel E. Brewer
, et al.
Abstract 1557: PHST001 combination with standard-of-care chemotherapy enhances macrophage-mediated elimination of tumor cells
2026
·
Giovanni C. Forcina
, Kelsey E. Hart
, et al.
·
Cancer Research
Show more works
View as search
Works count:
9
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type